Significant Biomarkers Identification Associated with Cutaneous Squamous Cell Carcinoma Progression

References

• Korhonen N, Ylitalo L, Luukkaala T, et al. Characteristics and trends of cutaneous squamous cell carcinoma in a patient cohort in Finland 2006–2015. Acta Derm Venereol. 2019;99:412–416.
   PubMed Web of Science ®Google Scholar
• Petit A, Hourbeigt K, Servagi-Vernat S, Visseaux L, Grange F. Factors associated with inoperable cutaneous squamous cell carcinoma. Eur J Dermatol. 2021;31(3):396–402. doi:10.1684/ejd.2021.4048
   PubMed Web of Science ®Google Scholar
• Filosa A, Filosa G. Actinic keratosis and squamous cell carcinoma: clinical and pathological features. Giornale italiano di dermatologia e venereologia. 2015;150(4):379–384.
   PubMed Web of Science ®Google Scholar
• Fuchs A, Marmur E. The kinetics of skin cancer: progression of actinic keratosis to squamous cell carcinoma. Dermatol Surg. 2007;33(9):1099–1101. doi:10.1111/j.1524-4725.2007.33224.x
   PubMed Web of Science ®Google Scholar
• Korhonen N, Ylitalo L, Luukkaala T, et al. Recurrent and metastatic cutaneous squamous cell carcinomas in a cohort of 774 patients in Finland. Acta Derm Venereol. 2020;100(8):adv00121. doi:10.2340/00015555-3479
   PubMed Web of Science ®Google Scholar
• Knuutila J, Riihilä P, Kurki S, Nissinen L, Kähäri V. Risk factors and prognosis for metastatic cutaneous squamous cell carcinoma: a cohort study. Acta Derm Venereol. 2020;100(16):adv00266. doi:10.2340/00015555-3628
   PubMed Web of Science ®Google Scholar
• Chen H, Yang J, Wu W. Seven key hub genes identified by gene co-expression network in cutaneous squamous cell carcinoma. BMC Cancer. 2021;21(1):852. doi:10.1186/s12885-021-08604-y
   PubMed Web of Science ®Google Scholar
• Zheng LQ, Li SY, Li CX. Expression profiling analysis of autophagy-related genes in perineural invasion of cutaneous squamous cell carcinoma. Oncol Lett. 2018;15(4):4837–4848. doi:10.3892/ol.2018.7971
   PubMed Web of Science ®Google Scholar
• Xu Y, Dong Y, Deng Y, et al. Identifying an lncRNA-related ceRNA network to reveal novel targets for a cutaneous squamous cell carcinoma. Biology. 2021;10(5):432. doi:10.3390/biology10050432
   PubMed Web of Science ®Google Scholar
• Mei XL, Zhong S. Long noncoding RNA LINC00520 prevents the progression of cutaneous squamous cell carcinoma through the inactivation of the PI3K/Akt signaling pathway by downregulating EGFR. Chin Med J. 2019;132(4):454–465. doi:10.1097/CM9.0000000000000070
   PubMed Web of Science ®Google Scholar
• Sun Y, Tu Y, He LI, Ji C, Cheng BO. High mobility group box 1 regulates tumor metastasis in cutaneous squamous cell carcinoma via the PI3K/AKT and MAPK signaling pathways. Oncol Lett. 2016;11(1):59–62. doi:10.3892/ol.2015.3843
   PubMed Web of Science ®Google Scholar
• Yao M, Shang YY, Zhou ZW, et al. The research on lapatinib in autophagy, cell cycle arrest and epithelial to mesenchymal transition via Wnt/ErK/PI3K-AKT signaling pathway in human cutaneous squamous cell carcinoma. J Cancer. 2017;8(2):220–226. doi:10.7150/jca.16850
   PubMed Web of Science ®Google Scholar
• Bito T, Sumita N, Ashida M, et al. Inhibition of epidermal growth factor receptor and PI3K/Akt signaling suppresses cell proliferation and survival through regulation of stat3 activation in human cutaneous squamous cell carcinoma. J Skin Cancer. 2011;2011:874571. doi:10.1155/2011/874571
   PubMedGoogle Scholar
• Nair S, Pillai MR. Human papillomavirus and disease mechanisms: relevance to oral and cervical cancers. Oral Dis. 2005;11(6):350–359. doi:10.1111/j.1601-0825.2005.01127.x
   PubMed Web of Science ®Google Scholar
• Struijk L, Ter Schegget J, Bouwes Bavinck JN, Feltkam P. [Human papillomavirus in the aetiology of skin cancer]. Ned Tijdschr Geneeskd. 2005;149(10):518–522. Dutch.
   PubMedGoogle Scholar
• Kocjan BJ, Steyer A, Sagadin M, Hosnjak L, Poljak M. Novel human papillomavirus type 174 from a cutaneous squamous cell carcinoma. Genome Announc. 2013;1(4). doi:10.1128/genomeA.00445-13
   Google Scholar
• Lin XY, He CD, Xiao T, et al. Acitretin induces apoptosis through CD95 signalling pathway in human cutaneous squamous cell carcinoma cell line SCL-1. J Cell Mol Med. 2009;13:2888–2898. doi:10.1111/j.1582-4934.2008.00397.x
   PubMed Web of Science ®Google Scholar
• Chaudhary SC, Kurundkar D, Elmets CA, Kopelovich L, Athar M. Metformin, an antidiabetic agent reduces growth of cutaneous squamous cell carcinoma by targeting mTOR signaling pathway. Photochem Photobiol. 2012;88(5):1149–1156. doi:10.1111/j.1751-1097.2012.01165.x
   PubMed Web of Science ®Google Scholar
• Chang D, Shain AH. The landscape of driver mutations in cutaneous squamous cell carcinoma. NPJ Genomic Med. 2021;6(1):61. doi:10.1038/s41525-021-00226-4
   PubMed Web of Science ®Google Scholar
• Fernandez Figueras MT. From actinic keratosis to squamous cell carcinoma: pathophysiology revisited. J Eur Acad Dermatol Venereol. 2017;31(Suppl 2):5–7. doi:10.1111/jdv.14151
   PubMed Web of Science ®Google Scholar
• Waldman A, Schmults C. Cutaneous squamous cell carcinoma. Hematol Oncol Clin North Am. 2019;33(1):1–12. doi:10.1016/j.hoc.2018.08.001
   PubMed Web of Science ®Google Scholar
• Fecker LF, Stockfleth E, Braun FK, et al. Enhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac/hyaluronic acid correlates with downregulation of c-FLIP. J Invest Dermatol. 2010;130(8):2098–2109. doi:10.1038/jid.2010.40
   PubMed Web of Science ®Google Scholar
• Soura E, Gagari E, Stratigos A. Advanced cutaneous squamous cell carcinoma: how is it defined and what new therapeutic approaches are available? Curr Opin Oncol. 2019;31(5):461–468. doi:10.1097/CCO.0000000000000566
   PubMed Web of Science ®Google Scholar
• Zheng Y, Chi S, Li C. Identification of potential gene drivers of cutaneous squamous cell carcinoma: analysis of microarray data. Medicine. 2020;99(39):e22257. doi:10.1097/MD.0000000000022257
   PubMed Web of Science ®Google Scholar
• Yan F, Tillman BN, Nijhawan RI, et al. High-risk cutaneous squamous cell carcinoma of the head and neck: a clinical review. Ann Surg Oncol. 2021;28(13):9009–9030. doi:10.1245/s10434-021-10108-9
   PubMed Web of Science ®Google Scholar
• Black AP, Ogg GS. The role of p53 in the immunobiology of cutaneous squamous cell carcinoma. Clin Exp Immunol. 2003;132(3):379–384. doi:10.1046/j.1365-2249.2003.02159.x
   PubMed Web of Science ®Google Scholar
• Warren TA, Broit N, Simmons JL, et al. Expression profiling of cutaneous squamous cell carcinoma with perineural invasion implicates the p53 pathway in the process. Sci Rep. 2016;6(1):34081. doi:10.1038/srep34081
   PubMed Web of Science ®Google Scholar
• Maruyama H, Ishitsuka Y, Fujisawa Y, Furuta J, Sekido M, Kawachi Y. B-Myb enhances proliferation and suppresses differentiation of keratinocytes in three-dimensional cell culture. Arch Dermatol Res. 2014;306(4):375–384. doi:10.1007/s00403-014-1450-1
   PubMed Web of Science ®Google Scholar
• Cicchillitti L, Jimenez S, Sala A, Saitta B. B-Myb acts as a repressor of human COL1A1 collagen gene expression by interacting with Sp1 and CBF factors in scleroderma fibroblasts. Biochem J. 2004;378(2):609–616. doi:10.1042/bj20031110
   PubMed Web of Science ®Google Scholar
• Bar-Shira A, Pinthus JH, Rozovsky U, Goldstein M, Orr-Urtreger A. Multiple genes in human 20q13 chromosomal region are involved in an advanced prostate cancer xenograft. Cancer Res. 2002;62(23):6803–6807.
   PubMed Web of Science ®Google Scholar
• Thorner A, Hoadley K, Parker J, Winkel S, Millikan R, Perou C. In vitro and in vivo analysis of B-Myb in basal-like breast cancer. Oncogene. 2009;28(5):742–751. doi:10.1038/onc.2008.430
   PubMed Web of Science ®Google Scholar
• Ke P, Chang Z. Mitotic degradation of human thymidine kinase 1 is dependent on the anaphase-promoting complex/cyclosome-CDH1-mediated pathway. Mol Cell Biol. 2004;24(2):514–526. doi:10.1128/MCB.24.2.514-526.2004
   PubMed Web of Science ®Google Scholar
• Wu C, Yang R, Zhou J, et al. Production and characterisation of a novel chicken IgY antibody raised against C-terminal peptide from human thymidine kinase 1. J Immunol Methods. 2003;277(1–2):157–169. doi:10.1016/S0022-1759(03)00062-0
   PubMed Web of Science ®Google Scholar
• Wu B, Li W, Qian C, Ding W, Zhou Z, Jiang H. Increased serum level of thymidine kinase 1 correlates with metastatic site in patients with malignant melanoma. Tumor Biol. 2013;34(2):643–648. doi:10.1007/s13277-012-0591-0
   PubMedGoogle Scholar